|
WO2013088445A1
|
|
Pyrimidine derivatives for treatment of inflammatory diseases
|
|
WO2013042120A2
|
|
Synthetic ubiquitins and use thereof in drug screening assays
|
|
AU2010322800A1
|
|
Small pyrimidine derivatives and methods of use thereof
|
|
AU2010322796A1
|
|
Quinazolin-4(3A)-one derivatives and methods of use thereof
|
|
WO2010134082A1
|
|
Chromenone derivatives for treatment of cancer
|
|
IL200991D0
|
|
Methods for enhancing the therapeutic efficacy of topoisomerase inhibitors
|
|
AU2008290220A1
|
|
Pyrimidine and pyridine derivatives as POSH and POSH-AP inhibitors
|
|
CA2675834A1
|
|
Methods for enhancing the therapeutic efficacy of topoisomerase inhibitors
|
|
CA2668859A1
|
|
Pyrimidine derivatives as posh and posh-ap inhibitors
|
|
WO2007088531A2
|
|
Pem-3-like polypeptides, complexes, and related methods
|
|
US2005214751A1
|
|
Inhibition of viral maturation, methods and compositions related thereto
|
|
US2005181453A1
|
|
Ubiquitin-based protein interaction assays and related compositions
|
|
US2006188890A1
|
|
Ubiquitin-based protein interaction assays and related compositions
|
|
AU2002309100A1
|
|
Compositions and methods for the modulation of viral maturation
|
